
|Slideshows|November 1, 2016
Neuro News Roundup: New MS Test & Stroke Risk
Author(s)Mark L. Fuerst
Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.
Advertisement
Highlights of three new studies in neurology include: a new test shows promise in diagnosing multiple sclerosis (MS) quickly by identifying gene patterns in the blood, headache disorders may be a risk factor for the development of new onset hypothyroidism, and a new risk prediction scale can help in the management and decision making for patients at risk for potentially lethal malignant edema after a stroke.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Repositioning GLP-1 Drugs for Neurologic Disease: Evidence, Advances, and Outlook
2
CAPN2-Targeting Agent AMX0114 Shows Safe Profile in Phase 1 LUMINA Trial of ALS
3
FDA Approves Inebilizumab for Myasthenia Gravis, Phase 3 PREVAiLS Study Launched, Tolebrutinib Fails Phase 3 PERSEUS Study
4
What the First Intrathecal Gene Therapy Means for SMA Clinicians and Researchers
5




















